Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Necrosis
New research on necrosis from A. Kajikawa and co-authors summarized
June 3rd, 2009
According to recent research published in the journal Applied and Environmental Microbiology, "The insertion of a heterologous gene into commensal bacteria is a common technique to develop a delivery agent for vaccination and therapies, but the pleiotropic effects of genetic modifications need to be investigated before its use in practical applications. Although supplemental properties provided by the expression of heterologous antigens have been reported, the negative or side effects on the immune-modulating properties caused by recombination are barely understood." "In the present study, we fortuitously found that the secretion of tumor necrosis factor alpha...
Source: Vaccine Weekly (2009-06-03)
|
